BioXcel Therapeutics Statistics
Total Valuation
BTAI has a market cap or net worth of $24.45 million. The enterprise value is $70.96 million.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BTAI has 40.74 million shares outstanding. The number of shares has increased by 13.99% in one year.
Shares Outstanding | 40.74M |
Shares Change (YoY) | +13.99% |
Shares Change (QoQ) | +30.40% |
Owned by Insiders (%) | 1.01% |
Owned by Institutions (%) | 14.70% |
Float | 29.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.83 |
Forward PS | 3.43 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 29.53 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35
Current Ratio | 2.35 |
Quick Ratio | 2.09 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.48 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -63.62% |
Return on Capital (ROIC) | -98.33% |
Revenue Per Employee | $32,473 |
Profits Per Employee | -$1.46M |
Employee Count | 74 |
Asset Turnover | 0.02 |
Inventory Turnover | 0.59 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.14% in the last 52 weeks. The beta is 0.28, so BTAI's price volatility has been lower than the market average.
Beta (5Y) | 0.28 |
52-Week Price Change | -74.14% |
50-Day Moving Average | 0.60 |
200-Day Moving Average | 1.80 |
Relative Strength Index (RSI) | 53.15 |
Average Volume (20 Days) | 350,730 |
Short Selling Information
The latest short interest is 516,384, so 1.27% of the outstanding shares have been sold short.
Short Interest | 516,384 |
Short Previous Month | 697,630 |
Short % of Shares Out | 1.27% |
Short % of Float | 1.74% |
Short Ratio (days to cover) | 0.78 |
Income Statement
In the last 12 months, BTAI had revenue of $2.40 million and -$107.83 million in losses. Loss per share was -$3.32.
Revenue | 2.40M |
Gross Profit | 1.04M |
Operating Income | -104.61M |
Pretax Income | -107.83M |
Net Income | -107.83M |
EBITDA | -104.30M |
EBIT | -104.61M |
Loss Per Share | -$3.32 |
Full Income Statement Balance Sheet
The company has $56.27 million in cash and $103.62 million in debt, giving a net cash position of -$47.35 million or -$1.16 per share.
Cash & Cash Equivalents | 56.27M |
Total Debt | 103.62M |
Net Cash | -47.35M |
Net Cash Per Share | -$1.16 |
Equity (Book Value) | -74.30M |
Book Value Per Share | -1.84 |
Working Capital | 36.89M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -105.33M |
Capital Expenditures | n/a |
Free Cash Flow | -105.33M |
FCF Per Share | -$2.59 |
Full Cash Flow Statement Margins
Gross Margin | 43.11% |
Operating Margin | -4,353.35% |
Pretax Margin | -4,487.39% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -4,383.15% |
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.99% |
Shareholder Yield | -13.99% |
Earnings Yield | -456.78% |
FCF Yield | -446.17% |
Analyst Forecast
The average price target for BTAI is $5.00, which is 733.33% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.00 |
Price Target Difference | 733.33% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 139.31% |
EPS Growth Forecast (5Y) | -48.90% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BTAI has an Altman Z-Score of -17.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -17.47 |
Piotroski F-Score | 2 |